glp-1 drugs depression tied to lower brain inflammation, higher risk The GLP-1 Agonists and Obesity:

Circulating microRNAs signature for predicting response to GLP1-RA therapy in type 2 diabetic patients: a pilot study

Mindful eating, or taking your time while eating, may also be beneficial as well

Neutrophiltolymphocyte ratio and lymphocytetoCreactive protein ratio in patients with severe coronavirus disease 2019 (COVID19): a metaanalysis

Weekly GLP-1 formulations tend to have better adherence rates compared to daily options

Although the SAVOR and EXAMINE studies were delineated to verify cardiovascular safety of two DPP-4i, namely saxagliptin and alogliptin, respectively, both are considered to be the first controlled clinical trials to address the effect of GLP-1 system on CVD

The drugmaker Altimmune says its new weekly injectable, pemvidutide, saw patients lose about 75% fat and only 25% muscle in results of a Phase II clinical trial the company announced on Wednesday